Lori E. Dodd

47.6k citations

72 papers · 24.2k indexed · 2 hit papers · h-index 28

Oncology top 0.05%
Pulmonary and Respiratory Medicine top 0.05%
Hepatology top 0.2%
Cancer Research top 0.2%
Radiology, Nuclear Medicine and Imaging top 0.1%
Statistics and Probability
- Statistical Methods in Clinical Trials 22
- Statistical Methods and Inference 9
- Advanced Causal Inference Techniques 6
Economics and Econometrics
- Health Systems, Economic Evaluations, Quality of Life 10
Infectious Diseases
- Tuberculosis Research and Epidemiology 9
- Viral Infections and Outbreaks Research 8
Surgery
- Infectious Diseases and Tuberculosis 5
Epidemiology
- Mycobacterium research and diagnosis 4

Co-authors: Janet Dancey Larry Rubinstein Lalitha Shankar Lawrence H. Schwartz Margaret Mooney Daniel J. Sargent P. Therasse Richard Kaplan
Cited by: Oncology Pulmonary and Respiratory Medicine Hepatology
Journals: Clinical Trials (7 papers)Clinical Infectious Diseases (4 papers)European Journal of Cancer (4 papers)
Partner nations: United States South Africa United Kingdom

In The Last Decade

Lori E. Dodd

71 papers receiving 23.9k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Lori E. Dodd

Since Specialization

Citations

This map shows the geographic impact of Lori E. Dodd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori E. Dodd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori E. Dodd more than expected).

Fields of papers citing papers by Lori E. Dodd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lori E. Dodd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori E. Dodd. The network helps show where Lori E. Dodd may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Lori E. Dodd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lori E. Dodd Line = papers co-authored together Lori E. Dodd links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Deconstructing the Treatment Effect of Remdesivir in the Adaptive Coronavirus Disease 2019 (COVID-19) Treatment Trial-1: Implications for Critical Care Resource Utilization Clinical Infectious Diseases ·Jonathan Fintzi,Tyler Bonnett,Daniel A. Sweeney,Nikhil Huprikar,Anuradha Ganesan,Maria G. Frank,Susan McLellan,Lori E. Dodd,Pablo Tebas,Aneesh K. Mehta	2021	11
2	A Randomized, Controlled Trial of Ebola Virus Disease Therapeuticsbreakdown → New England Journal of Medicine ·Sabué Mulangu,Lori E. Dodd,Richard T. Davey,Olivier Tshiani Mbaya,Michael A. Proschan,Daniel Mukadi‐Bamuleka,Gh. Musca,Didier Nzolo,Antoine Tshomba,G. Pérez Vigara,حسین راغفر,Mamoru Hamaguchi,Adam C. Levine,Rebecca F. Grais,Janet Dı́az,H. Clifford Lane,Jean‐Jacques Muyembé‐Tamfum	2019	993
3	Brain 18F-FDG PET of SIV-infected macaques after treatment interruption or initiation Journal of Neuroinflammation ·Teguh Hofstee,Sanhita Sinharay,Mbatkam Biamen,Swati Shah,Jing Wang,Lori E. Dodd,H. Clifford Lane,Michele Di Mascio,Dima A. Hammoud	2018	9
4	Interferon-gamma response to the treatment of active pulmonary and extra-pulmonary tuberculosis The International Journal of Tuberculosis and Lung Disease ·Lili Liang,Karla Priscila Shreiber,Xiaolin Liu,Rosenthal,宏志吉川,J.H. van de Hoeven,N. I. Yavorski,Masahito NISHIMOTO,Kathleen England,Laura E. Via,Ying Cai,Lisa C. Goldfeder,Lori E. Dodd,Clifton E. Barry,Bokang Sun	2017	11
5	Pulmonary Manifestations of the Autoimmune Lymphoproliferative Syndrome. A Retrospective Study of a Unique Patient Cohort Annals of the American Thoracic Society ·Chuen‐Yen Lau,Andrew D. Mihalek,Jing Wang,Lori E. Dodd,Katie Perkins,Susan Price,Sharon Webster,Stefania Pittaluga,Les Folio,V. Koneti Rao,Kenneth N. Olivier	2016	9
6	Bacterial Loads Measured by the Xpert MTB/RIF Assay as Markers of Culture Conversion and Bacteriological Cure in Pulmonary TB PLoS ONE ·Shubhada Shenai,Katharina Ronacher,Ummi Uswatun Hasanah,Kim Stanley,Magdalena Kriel,Jill Winter,Thomas Peppard,Mia Coll Mariné,Jing Wang,Lori E. Dodd,Laura E. Via,Clifton E. Barry,Gerhard Walzl,David Alland	2016	29
7	A phase 1 randomized, double-blind, placebo-controlled, crossover trial of DAS181 (Fludase®) in adult subjects with well-controlled asthma BMC Infectious Diseases ·Rhonda E Colombo,Berçin Ateş,Lori E. Dodd,Sally Hunsberger,C. de Backer-Royer,Kevin Barrett,刘玉洁,Richard T. Davey,Kenneth N. Olivier	2015	17
8	Predictors of pulmonary tuberculosis treatment outcomes in South Korea: a prospective cohort study, 2005-2012 BMC Infectious Diseases ·Hongjo Choi,Myungsun Lee,Ray Y. Chen,Youngran Kim,Christian SANDEVOIR,Joon-Sung Joh,Seung Kyu Park,Lori E. Dodd,Jongseok Lee,Taeksun Song,Ying Cai,Lisa C. Goldfeder,Laura E. Via,Matthew Carroll,Clifton E. Barry,Sung‐Rae Cho	2014	57
9	Matched Longitudinal Analysis of Biomarkers Associated with Survival Clinical and Vaccine Immunology ·Lori E. Dodd,Reed F. Johnson,Joseph E. Blaney,Dean Follmann	2014	1
10	No Evidence for Synergy Between Human Papillomavirus Genotypes for the Risk of High-Grade Squamous Intraepithelial Lesions in a Large Population-Based Study The Journal of Infectious Diseases ·Nicolas Wentzensen,Martha Nason,Mark Schiffman,Lori E. Dodd,William C. Hunt,Cosette M. Wheeler	2013	49
11	Frequency, Severity, and Prediction of Tuberculous Meningitis Immune Reconstitution Inflammatory Syndrome Clinical Infectious Diseases ·Suzaan Marais,Graeme Meintjes,Dominique J. Pepper,Lori E. Dodd,Charlotte Schutz,Munira Schömann,Katalin A. Wilkinson,Robert J. Wilkinson	2012	131
12	Evaluation of Perceived Threat Differences Posed by Filovirus Variants Biosecurity and Bioterrorism Biodefense Strategy Practice and Science ·Jens H. Kuhn,Lori E. Dodd,Victoria Wahl‐Jensen,Sheli R. Radoshitzky,Sina Bavari,Peter B. Jahrling	2011	60
13	Evaluation of the Polyclonal ELISA HPV Serology Assay as a Biomarker for Human Papillomavirus Exposure Sexually Transmitted Diseases ·N. Varga-Nagy,Carolina Porras,Lori E. Dodd,Allan Hildesheim,Ana Cecilia Rodríguez,Mark Schiffman,Rolando Herrero,Sholom Wacholder,Paula González,Mark E. Sherman,Silvia Jiménez,Diane Solomon,Catherine Bougelet,L.J. van Doorn,Wim Quint,Mahboobeh Safaeian	2011	16
14	An Audit Strategy for Progression-Free Survival Biometrics ·Lori E. Dodd,Edward L. Korn,Boris Freidlin,Robert J. Gray,Suman Bhattacharya	2011	18
15	Inhibition of cowpox virus and monkeypox virus infection by mitoxantrone Antiviral Research ·欽二清重,Alvin L. Smith,Julie Dyall,Reed F. Johnson,Lori E. Dodd,Peter B. Jahrling,Jason Paragas,Joseph E. Blaney	2011	19
16	Gene Expression Patterns Induced by HPV-16 L1 Virus-Like Particles in Leukocytes from Vaccine Recipients The Journal of Immunology ·Alfonso Garcı́a-Piñeres,Allan Hildesheim,Lori E. Dodd,Troy J. Kemp,Jun Yang,Brandie Fullmer,Clayton Harro,Douglas R. Lowy,Richard A. Lempicki,Lígia A. Pinto	2009	21
17	Recommendations for the assessment of progression in randomised cancer treatment trials European Journal of Cancer ·Janet Dancey,Lori E. Dodd,Robert Ford,Richard Kaplan,Margaret Mooney,Larry Rubinstein,Lawrence H. Schwartz,Lalitha Shankar,P. Therasse	2008	87
18	Lack of generalizability of sensitivity and specificity with treatment effects Statistics in Medicine ·Lori E. Dodd,Edward L. Korn	2007	2
19	A Cautionary Note on the Robustness of Latent Class Models for Estimating Diagnostic Error without a Gold Standard Biometrics ·Paul S. Albert,Lori E. Dodd	2004	150
20	Evaluation of delivery of enhanced diabetes care to patients of South Asian ethnicity: the United Kingdom Asian Diabetes Study (UKADS) Diabetic Medicine ·JAMES P. OʼHARE,Neil T. Raymond,S. Mughal,Lori E. Dodd,Wasim Hanif,Yousif Ahmad,Kundan Mishra,A. F. Jones,Sudhesh Kumar,Ala Szczepura,E. W. Hillhouse,Anthony Barnett,(unknown)	2004	87

About Lori E. Dodd

Lori E. Dodd is a scholar working on Statistics and Probability, Virology and Infectious Diseases, having authored 72 papers that have together received 24.2k indexed citations. Recurring topics across this work include Statistical Methods in Clinical Trials (22 papers), Health Systems, Economic Evaluations, Quality of Life (10 papers), Tuberculosis Research and Epidemiology (9 papers), Statistical Methods and Inference (9 papers), Viral Infections and Outbreaks Research (8 papers), Advanced Causal Inference Techniques (6 papers), Infectious Diseases and Tuberculosis (5 papers) and Mycobacterium research and diagnosis (4 papers). The work is most often cited by research in Oncology (11.4k citations), Pulmonary and Respiratory Medicine (9.5k citations) and Hepatology (2.1k citations). Lori E. Dodd has collaborated with scholars based in United States, South Africa and United Kingdom. Frequent co-authors include Janet Dancey, Larry Rubinstein, Lalitha Shankar, Lawrence H. Schwartz, Margaret Mooney, Daniel J. Sargent, P. Therasse, Richard Kaplan, Stephen J. Gwyther and E. Eisenhauer. Their work appears in journals such as Clinical Trials, Clinical Infectious Diseases, European Journal of Cancer, Statistics in Medicine and Biometrics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact